- Eligible commercially insured patients with Zepbound coverage may pay as low as $25 for a 1-, 2-, or 3-month single-dose pen fill
- Eligible commercially insured patients without coverage may pay as low as $499 for a 1-month single-dose pen fill
- Self-pay through LillyDirect currently starts at $299 (2.5 mg), $399 (5 mg), and $449 for 7.5-15 mg when Journey Program refill timing requirements are met
- Savings terms, caps, and pricing can change, so re-check Lilly terms before each fill
- PEAK helps you find all available savings options so you pay the least possible
Important GLP-1 safety warning: Zepbound carries a boxed warning for thyroid C-cell tumors. Avoid use in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
Eli Lilly’s Zepbound savings program
Eli Lilly, the manufacturer of Zepbound (tirzepatide), offers a manufacturer savings card designed to reduce what patients pay at the pharmacy. The current program includes one path for eligible patients with commercial coverage and a separate path for eligible patients with commercial insurance whose plan does not cover Zepbound.
Manufacturer savings cards are common in the pharmaceutical industry. For covered claims, they typically function as a secondary payer after your insurance processes the claim. Lilly also offers a separate non-covered commercial pathway in its current Zepbound card terms.
Savings cards help bridge the gap between what insurance covers and what patients can afford. For high-cost specialty medications like Zepbound, the copay alone can be a barrier to starting or staying on treatment. Lilly’s savings program is designed to remove that barrier for commercially insured patients.
Eligibility requirements
The Zepbound savings card is not available to everyone. Eli Lilly sets specific eligibility criteria that determine who qualifies.
General eligibility requirements include:
- Commercial insurance — You must have private or employer-sponsored drug coverage. There are separate card terms for commercially insured patients with coverage and commercially insured patients without coverage.
- Not government-funded insurance — Patients with Medicare (including Part D), Medicaid, TRICARE, VA benefits, or other government-funded programs are not eligible for the manufacturer savings card. This is a federal requirement, not a Lilly policy.
- U.S. or Puerto Rico residency and age — Terms require that you are a resident of the United States or Puerto Rico and are 18 years of age or older.
- No alternate funding program (AFP) — If your insurance requires use of certain alternate funding vendors as a condition for coverage, Lilly states you are not eligible for the savings card.
Note: PEAK accepts commercial insurance and TRICARE. We do not accept Medicare or Medicaid.
Manufacturer savings programs are updated periodically. Eligibility requirements, savings amounts, and program duration can change at any time. Always verify current terms through your provider or the Eli Lilly website before relying on specific program details.
Savings amounts
As of March 8, 2026, Lilly lists the following Single-Dose Pen Savings Card terms. These terms can change, so always re-check before each fill.
What commercially insured patients should understand:
- If your commercial plan covers Zepbound — Lilly currently advertises cost as low as $25 for a 1-, 2-, or 3-month single-dose pen fill. Published caps are up to $100 (1-month), $200 (2-month), or $300 (3-month) per fill, with up to $1,300 annual savings and up to 13 fills per year.
- If your commercial plan does not cover Zepbound — Lilly currently advertises cost as low as $499 for a 1-month single-dose pen fill. Published caps are up to $620 per month, up to $8,060 annual savings, and up to 13 fills per year.
- Program duration — Current terms state card savings end on 12/31/2026 unless changed earlier by Lilly.
- Formulation limits — Lilly’s savings card terms are specific to Zepbound single-dose pens, while self-pay vial/KwikPen pricing is handled under separate LillyDirect terms.
Current savings-card terms include both a covered-commercial path and a non-covered-commercial path, each with different limits and caps.
How to activate
Activating the Zepbound savings card is a straightforward process, but the exact steps may depend on how the program is structured at the time you enroll.
Common activation methods include:
- Lilly’s website. Visit the Zepbound section of Eli Lilly’s website and look for the savings card or savings program page. You will typically need to provide basic information and confirm eligibility. You may receive a digital card with a BIN, PCN, and group number to present at the pharmacy.
- Your provider’s office. Many prescribing clinicians, including PEAK, can help you enroll in the savings program during your appointment. We can provide the card details or activate the card on your behalf as part of our cost navigation process.
- At the pharmacy. In some cases, your pharmacist may be able to apply the savings card at the point of sale. Bring any card details you have received — physical or digital — and ask the pharmacy to run it as a secondary payer after your insurance processes.
The savings card should be set up before you pick up your prescription. If you arrive at the pharmacy without the card details, you may pay full copay and need to seek retroactive reimbursement — which is often more complicated. At PEAK, we help you activate the card before your prescription is sent to the pharmacy.
Self-pay savings
For patients who use self-pay, Lilly currently lists direct-purchase pricing through LillyDirect. These options are separate from the Single-Dose Pen Savings Card and have their own terms.
As of March 8, 2026, listed self-pay options include:
- Base self-pay prices through LillyDirect — Lilly currently lists starting prices of $299 per 28-day supply for 2.5 mg and $399 for 5 mg (defined as 1 KwikPen or 4 vials).
- Journey Program pricing for higher doses — Lilly currently lists $449 per 28-day supply for 7.5 mg, 10 mg, 12.5 mg, and 15 mg when refill purchases are completed within 45 days of the previous delivery/receipt date.
- Regular price if refill timing is missed — Lilly lists regular prices of $499 for 7.5 mg and $699 for 10 mg, 12.5 mg, and 15 mg when Journey timing requirements are not met. Additional taxes and fees may apply.
Self-pay pricing and program availability can change with little notice. Always verify current self-pay options directly with Eli Lilly or LillyDirect before making decisions based on a specific price point.
Insurance + savings card strategy
The most cost-effective approach for most patients is to combine insurance coverage with the manufacturer savings card. This stacking strategy minimizes your total out-of-pocket expense.
Here is how the strategy works in practice:
- Get insurance approval first. Work with your provider to obtain prior authorization and confirm that your plan covers Zepbound. Insurance pays the largest portion of the cost.
- Apply the savings card on top. Once insurance processes the claim, the savings card covers part or all of the remaining copay. Your final cost is whatever is left after both insurance and the savings card have been applied.
- Monitor your deductible status. If your plan requires you to meet a deductible before Zepbound is covered, the savings card may not provide full benefit until the deductible is met. In some cases, the savings card payments count toward your deductible; in others, they do not. Check your plan documents or ask your insurer.
| Payment layer | What it covers |
|---|---|
| Insurance (primary) | Covers the bulk of the medication cost after prior authorization approval |
| Savings card (secondary) | Reduces or eliminates the remaining copay or coinsurance |
| Patient (remaining) | Pays whatever remains after insurance and savings card — often very little |
Insurance brings the cost down from list price. The savings card brings your copay down further. Together, they make Zepbound affordable for many patients.
Alternative cost strategies
If the savings card does not fully solve your cost problem — or if you are not eligible — there are additional strategies worth exploring.
- Appeal insurance denials. If your plan denied Zepbound coverage, you have the right to appeal. Many initial denials are overturned on appeal when documentation is thorough. Your clinician can request a peer-to-peer review with the insurance company’s medical director or submit a formal written appeal.
- Sleep apnea coverage pathway. Zepbound received FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity. If you have a documented sleep apnea diagnosis, your provider may be able to pursue coverage under this indication, which sometimes has different formulary rules than the weight management indication.
- Switch to Wegovy if better covered. If your plan covers Wegovy (semaglutide) but not Zepbound, switching to a covered medication may be a practical solution. Wegovy is a GLP-1 receptor agonist, while Zepbound (tirzepatide) is a dual GIP and GLP-1 receptor agonist; your clinician can help determine the best fit.
- Re-check current manufacturer terms before each refill. Lilly updates savings-card and self-pay terms over time. Before each fill, confirm the current terms, caps, and expiration dates on the official Zepbound savings page so there are no surprises at pickup.
PEAK’s cost navigation
Working through savings programs, insurance approvals, and alternative pathways takes time and knowledge. At PEAK, our team handles cost navigation as part of your care — not as an afterthought.
Here is what we do:
- Verify your insurance. Before your first appointment, we check whether your plan covers Zepbound, what your copay structure looks like, and whether prior authorization is required.
- Connect you to savings programs. We enroll eligible patients in the Eli Lilly savings card, help activate the card, and ensure it is applied at the pharmacy. If self-pay options are a better fit, we help you navigate those current LillyDirect pathways.
- Explore all options. If Zepbound is not covered or remains too expensive after savings programs, we evaluate alternatives — including other covered GLP-1 medications, appeal strategies, and the sleep apnea coverage pathway.
- Provide transparent cost estimates. Before you fill your first prescription, we give you a clear picture of what you will pay. No surprises, no guesswork.
We want cost to be a solved problem, not an ongoing stressor. Every patient at PEAK receives cost navigation support as part of their treatment plan. If a more affordable path exists, we help you find it.
